Intrathoracic core needle biopsy and repeat biopsy for PD-L1 evaluation in non-small cell lung cancer

Over the past years, the improved knowledge on the biological, genetic and molecular heterogeneity of tumors, together with the development of pharmaceutical technologies, has allowed the identification of several targets for novel therapeutic strategies.